NCT00667719 - A Long Term Safety Study to Test the Combination of Aliskiren/ Amlodipine / Hydrochlorothiazide in Participants With Essential Hypertension | Biotech Hunter

Enrollment

564

Participants

Timeline

Start Date

June 5, 2008

Primary Completion Date

October 5, 2009

Study Completion Date

October 5, 2009

Conditions

Essential Hypertension

Interventions

DRUG

Aliskiren

300 mg tablet

DRUG

Amlodipine

5 mg tablet

DRUG

Hydrochlorothiazide

12.5 mg and 25 mg capsule

Trial Locations (8)

Investigative Site, Houston

Investigative Site, Belgium

Investigative Site, Egypt

Investigative Site, Germany

Investigative Site, Poland

Investigative Site, Slovakia

Investigative Site, Spain

Investigative Site, Turkey